Letter to the editor regarding “Dosing Interval Extension of Dupilumab in CRSwNP: Five‐Year Real World Outcomes”

Fleur L. Meulmeester, Camiel J. M. Marijnissen, Jacob K. Sont
International Forum of Allergy and Rhinology · Wiley · 2026-11-04 · DOI: 10.1002/alr.70291

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles